<DOC>
	<DOCNO>NCT01732757</DOCNO>
	<brief_summary>This study evaluate efficacy Lastacaft® ( Alcaftadine 0.25 % ) Pataday™ ( Olopatadine 0.2 % ) compare placebo prevention ocular itch associate allergic conjunctivitis .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Lastacaft® Compared Pataday™ Placebo Patients With Acute Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Alcaftadine</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>History ocular allergy within past 24 month . Able avoid wear contact lens least 72 hour prior study trial period . Any presence active ocular infection history ocular herpetic infection . Ocular surgery within 3 month prior first visit refractive surgery within past 6 month . Have plan surgery study 30 day study .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>